A pilot electroencephalography (EEG) study to evaluate the effect of CT1812 treatment on synaptic activity in subjects with mild to moderate alzheimer?s disease

Ended Project Grant Awarded Last action

Award ID
RF1AG058710
Recipient
Awarding agency
Obligated
$9,733,869

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $2,144,409
Amendment $2,144,409
Amendment $2,144,409
Amendment $1,065,073
Amendment $1,065,073
Amendment $1,065,073
Amendment $0
Amendment $0
Amendment $0
Amendment -$1,065,073
Amendment -$1,065,073
Amendment -$1,065,073
Amendment $0
Amendment $0
Amendment $969,299
Amendment $0
Original award $2,331,343
Show all 20

Quick answers

Who received award RF1AG058710?

RF1AG058710 was awarded to Cognition Therapeutics, Inc. by National Institute on Aging (National Institutes of Health) on July 1, 2019.

How much is award RF1AG058710 worth?

$9,733,869 has been obligated on RF1AG058710.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award